Skip to main content
Erschienen in: Reactions Weekly 1/2015

01.05.2015 | Case report

Bevacizumab

Leucopenia: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2015

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (FDA MedWatch definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * requires intervention to prevent permanent impairment or damage
Fußnoten
1
In this study, the patients received bevacizumab alone or in combination with irinotecan. It was not confirmed that our patient received bevacizumab alone or in combination with irinotecan.
 
Metadaten
Titel
Bevacizumab
Leucopenia: case report
Publikationsdatum
01.05.2015
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2015
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-015-1829-6

Weitere Artikel der Ausgabe 1/2015

Reactions Weekly 1/2015 Zur Ausgabe

Case report

Methotrexate

Case report

Axitinib

Case report

Rituximab

Case report

Mercaptopurine